nc-503
Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK companyPhase 2/3
—
Rating in progress
nc-503 in Secondary (AA) Amyloidosis is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant